A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A to Develop a Pipeline of Selective Tumor Cell Therapeutics
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
RedMarlin, Deep Learning-Powered Fraud Prevention Company, Raises $10M In Series A Funding
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Pathstone Selects Lovell Minnick Partners as Strategic Partner
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Riskified Announces $165 Million Series E Funding Round Led by General Atlantic
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Founded by Ex-Uber Engineers, Chronosphere Emerges to Push Observability and Cloud Native Monitoring to New Levels With $11 Million in Funding
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
H.I.G. Capital Completes Acquisition of BioVectra
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Shape Therapeutics, Inc. Raises $35.5M Series A Financing, Led by NEA and Announces the Formation of a World-Class Scientific Advisory Board, to Advance a First-in-Class RNA Editing Gene Therapy Platform Focused on Curing Genetic Diseases
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
HarbourVest Partners Closes Canada Growth Fund II
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Funds advised by Apax Partners to acquire Lexitas from Trinity Hunt
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
Diality Secures $10 million in Series A Funding
VIEW ARTICLE If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.